Cempra: How Cempra's shareholder vote on Melinta merger shook out

Chapel Hill-based Cempra (Nasdaq: CEMP) held its 2017 stockholders meeting Friday. On the agenda: the company's planned merger with New Haven, Connecticut-based Melinta Therapeutics. Following the meeting, Cempra announced that, while a number of merger-related proposals were approved, there were two that were not. Approved: Cempra went on to state that, "Stockholders also approved on a non-binding advisory basis Cempra's 2016 executive compensation [and] Stockholders elected each of the...